Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate

Amphotericin B lipid complex (ABLC) was introduced in the late 1990s as a less toxic alternative to amphotericin B (AmB) deoxycholate. ABLC is a safe and effective broad-spectrum drug in the treatment of invasive fungal infections in patients with infection refractory to AmB deoxycholate or in patie...

Descripción completa

Detalles Bibliográficos
Autor principal: Chandrasekar, PH
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643109/
https://www.ncbi.nlm.nih.gov/pubmed/19337435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643109/
https://www.ncbi.nlm.nih.gov/pubmed/19337435

Ejemplares similares